Connor, Clark & Lunn Investment Management Ltd. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$703,310
-54.6%
17,340
-63.0%
0.00%
-60.0%
Q3 2022$1,548,000
-49.3%
46,843
-46.0%
0.01%
-47.4%
Q2 2022$3,056,000
-0.0%
86,793
+30.6%
0.02%
+26.7%
Q1 2022$3,057,000
+44.6%
66,474
+108.5%
0.02%
+50.0%
Q4 2021$2,114,000
-49.0%
31,878
-51.9%
0.01%
-54.5%
Q3 2021$4,142,000
+43.0%
66,343
+89.7%
0.02%
+46.7%
Q2 2021$2,896,000
+1721.4%
34,970
-64.3%
0.02%
+1400.0%
Q2 2017$159,000
+231.2%
97,875
+275.0%
0.00%
Q1 2017$48,00026,1000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders